
ICU Medical, Inc.
ICUINASDAQHealthcareMedical - Instruments & Supplies
前收盤價
US$182.84
+US$0.31 · +0.17%
ICUI公司概覽
盤中時間採用ET。市場資料可能有所延遲。
GoAI 研究快照
簡明呈現最新可用的模型資訊。
GoAI評分
Hold
Wait — insufficient conviction to act
估值
58
Fair Value
動能
60
Neutral
情緒
68
Bullish
風險韌性
70
Moderate Risk
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
人工智慧產生的上下文僅供參考,並非投資建議。
公司概況
公司網站ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
- 產業
- Medical - Instruments & Supplies
- 部門
- Healthcare
- 總部
- US
- 執行長
- Vivek Jain
- 上市以來
- 1992年3月31日
- 僱員
- 13,000
市場位置
日內區間
目前US$182.84,
52週區間
目前US$182.84,
- 開盤價
- US$182.15
- 前收盤價
- US$182.53
- 成交量
- 18.23萬
- 0.6× 平均值
- 平均成交量
- 30.59萬
- 日均成交量
- 市值
- 45.7億 USD
- 貝塔
- 0.75
- 市場參考 1
- 50天平均值
- US$160.63
- 高於平均水平+13.82%
- 200天平均值
- US$143.66
- 高於平均水平+27.27%
財務數據
財務快照
最近十二個月估值與收益率
- 企業價值
- 46億 USD
- 本益比(TTM)
- 152.37×
- 股價淨值比(TTM)
- 2.12×
- 股價營收比(TTM)
- 2.12×
- EV/EBITDA
- 14.09×
- 盈餘收益率
- 0.02%
- 自由現金流收益率
- 2.61%
- 股息率
- 0.00%
獲利能力和效率
- 毛利率
- 37.56%
- 營業利益率
- 5.04%
- 淨利潤率
- 1.39%
- 股東權益報酬率
- 0.03%
- 資產報酬率
- 0.02%
- 投入資本報酬率
- 0.69%
財務健康
- 負債權益比
- 0.59×
- 流動比率
- 2.36×
- 奧特曼 Z 分數
- 2.56
- 皮奧特羅斯基 F 分數
- 6 共 9 個
財務報表
利潤率趨勢
獲利能力占已公布營收的百分比。
損益趨勢
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 22.3億 USD | 23.82億 USD | 22.59億 USD | 22.8億 USD | 13.16億 USD |
| 銷貨成本 | 14.1億 USD | 15.57億 USD | 15.19億 USD | 15.82億 USD | 8.25億 USD |
| 毛利 | 8.2億 USD | 8.25億 USD | 7.4億 USD | 6.98億 USD | 4.91億 USD |
| 研究與開發 | 8749.5萬 USD | 8861.5萬 USD | 8534.4萬 USD | 9298.4萬 USD | 4749.8萬 USD |
| 銷售、一般及管理費用 | 6.25億 USD | 6.39億 USD | 6.07億 USD | 6.08億 USD | 3.03億 USD |
| 營業費用 | 7.13億 USD | 7.82億 USD | 7.17億 USD | 7.41億 USD | 3.68億 USD |
| 利息收入 | 1030.7萬 USD | 1078.8萬 USD | 750.8萬 USD | 443萬 USD | 284萬 USD |
| 利息支出 | 1.05億 USD | 1.07億 USD | 1.03億 USD | 7080.5萬 USD | 85.8萬 USD |
| 折舊和攤銷 | 2.18億 USD | 243.5萬 USD | 2.29億 USD | 2.35億 USD | 9929.2萬 USD |
| 營業利益 | 1.07億 USD | 4296.4萬 USD | 2282.5萬 USD | −4289.8萬 USD | 1.23億 USD |
| 淨利 | 73.2萬 USD | −1.18億 USD | −2965.5萬 USD | −7428.6萬 USD | 1.03億 USD |
公司資料更新於 2026年8月24日。
分析師評級
第三方分析師預期可能變動,並非 GoAI 建議。
評級分佈
12項評級ICUI同業公司
持有ICUI的ETF
報告持有此股票曝險的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR2.78億0.25%1111.89億 USD0.06%US$147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI1.34億0.01%2.3兆 USD0.03%US$378.24+0.44%
iShares Russell 2000 ETFIWM1.14億0.14%816.21億 USD0.19%US$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB9688.6萬0.05%1834億 USD0.03%US$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR6149.54萬0.09%683億 USD0.05%US$249.18+0.68%
Vanguard Extended Market ETFVXF4849.58萬0.05%937億 USD0.05%US$245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM4284.55萬0.25%170.31億 USD0.03%US$57.28+0.61%
iShares Russell 2000 Value ETFIWN4219.53萬0.29%146.6億 USD0.24%US$224.81+0.45%
iShares Core S&P Small-Cap ETFIJR- 市場價值
- 2.78億
- 重量
- 0.25%
- AUM
- 1111.89億 USD
- 費用率
- 0.06%
- 價格 / 1日
- US$147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI- 市場價值
- 1.34億
- 重量
- 0.01%
- AUM
- 2.3兆 USD
- 費用率
- 0.03%
- 價格 / 1日
- US$378.24+0.44%
iShares Russell 2000 ETFIWM- 市場價值
- 1.14億
- 重量
- 0.14%
- AUM
- 816.21億 USD
- 費用率
- 0.19%
- 價格 / 1日
- US$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB- 市場價值
- 9688.6萬
- 重量
- 0.05%
- AUM
- 1834億 USD
- 費用率
- 0.03%
- 價格 / 1日
- US$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR- 市場價值
- 6149.54萬
- 重量
- 0.09%
- AUM
- 683億 USD
- 費用率
- 0.05%
- 價格 / 1日
- US$249.18+0.68%
Vanguard Extended Market ETFVXF- 市場價值
- 4849.58萬
- 重量
- 0.05%
- AUM
- 937億 USD
- 費用率
- 0.05%
- 價格 / 1日
- US$245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM- 市場價值
- 4284.55萬
- 重量
- 0.25%
- AUM
- 170.31億 USD
- 費用率
- 0.03%
- 價格 / 1日
- US$57.28+0.61%
iShares Russell 2000 Value ETFIWN- 市場價值
- 4219.53萬
- 重量
- 0.29%
- AUM
- 146.6億 USD
- 費用率
- 0.24%
- 價格 / 1日
- US$224.81+0.45%
繼續GoAI的研究
在 GoAI 中研究ICUIresearch.disclaimer





